Literature DB >> 29257201

The regulatory role of Fos related antigen‑1 in inflammatory bowel disease.

Xianren Wang1, Renle Guo2, Yanfeng Lv3, Rongzhan Fu1.   

Abstract

The etiology of inflammatory bowel disease (IBD) remains unclear. The ratio of Fos related antigen‑1 (Fra‑1)‑positive intestinal mucosa epithelial cells is significantly increased in active IBD. This study intends to explore the regulatory role of Fra‑1 in IBD. The Fra‑1 eukaryotic expression vector was constructed and stably transfected to establish the Fra‑1 overexpression HCT‑116 (116‑Fra‑1) intestinal epithelial cell line. The impact of Fra‑1 overexpression on intestinal mucosal epithelial cell damage repair function was tested using a scratch assay. The role of Fra‑1 overexpression on intestinal mucosal epithelial cell proliferation was evaluated using a Cell Counting Kit-8 assay. Apoptosis related proteins, B‑cell lymphoma 2 (Bcl‑2), c‑Myc, Survivin and Bcl‑extra large (Bcl‑xL), expression levels were detected by western blotting. Fra‑1 suppressed intestinal mucosal epithelial cell damage repair and proliferation. Fra‑1 inhibited the protein levels of Bcl‑2, c‑Myc, Survivin, and Bcl‑xL. Fra‑1 overexpression in intestinal mucosal epithelial cells may restrain damage repair after intestinal mucosal injury in IBD remittent period through weakening the protective effect of intestinal mucosa, thus increasing the risk of recurrence. Therefore, suppressing Fra‑1 expression in intestinal mucosal epithelial cells may contribute to IBD remittent maintenance and recurrence delay.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29257201     DOI: 10.3892/mmr.2017.8071

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  2 in total

1.  Identification of differential gene expression in endothelial cells from young and aged mice using RNA-Seq technique.

Authors:  Liang Zhang; Manli Liu; Qing Li; Bing Shen; Chaojie Hu; Rui Fu; Mengdie Liu; Jie Deng; Qi Cao; Yiping Wang; Yuanmin Wang
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

2.  FOSL1 knockdown ameliorates DSS-induced inflammation and barrier damage in ulcerative colitis via MMP13 downregulation.

Authors:  Lizhuan Ma; Xiujing Zhang; Chao Zhang; Bingxu Hou; Hongtao Zhao
Journal:  Exp Ther Med       Date:  2022-07-01       Impact factor: 2.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.